GeneOne Life Science, Inc. (KRX:011000)
South Korea · Delayed Price · Currency is KRW
787.00
+67.00 (9.31%)
Last updated: Apr 16, 2026, 2:23 PM KST
Revenue by Segment
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
|---|
| | 12.75B | 15.88B | 14.34B | 13.54B | 16.68B | | | | |
| | -19.71% | 10.70% | 5.94% | -18.82% | 7.28% | | | | |
| | 27.45B | 32.84B | 24.36B | 27.96B | 24.56B | | | | |
Pharmaceutical Business Growth | | -16.40% | 34.83% | -12.90% | 13.85% | 31.03% | | | | |
| | 40.20B | 48.72B | 38.70B | 41.50B | 41.24B | | | | |
| | -17.48% | 25.89% | -6.75% | 0.63% | 20.26% | | | | |
Revenue by Geography
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
|---|
| | 4.12B | 4.54B | 3.29B | 2.79B | 3.59B | | | | |
| | -9.29% | 38.00% | 17.83% | -22.35% | 13.07% | | | | |
| | 36.09B | 44.18B | 35.41B | 38.71B | 37.65B | | | | |
| | -18.32% | 24.76% | -8.52% | 2.83% | 21.00% | | | | |
| | 40.20B | 48.72B | 38.70B | 41.50B | 41.24B | | | | |
| | -17.48% | 25.89% | -6.75% | 0.63% | 20.26% | | | | |
Source: S&P Global Market Intelligence.